Germany vs Iran, Islamic Republic of: Treatment success rate: previously treated TB cases
Germany
64
in 2023
Iran, Islamic Republic of
65
in 2023
Germany rank
109th
Iran, Islamic Republic of rank
107th
Treatment success rate: previously treated TB cases over time
- Germany
- Iran, Islamic Republic of
How they compare
Iran, Islamic Republic of currently reports 65 against 64 in Germany, a difference of 1.
The two have swapped places 4 times across 26 shared years of data; in 1997 it was Iran, Islamic Republic of ahead.
Germany ranks 109th and Iran, Islamic Republic of ranks 107th of 179 countries.
Iran, Islamic Republic of has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Germany | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 53.5 | 74 | 20.5 | Iran, Islamic Republic of |
| 2000s | 62.8 | 74.9 | 12.1 | Iran, Islamic Republic of |
| 2010s | 59.8 | 76.6 | 16.8 | Iran, Islamic Republic of |
| 2020s | 58 | 70.25 | 12.25 | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: previously treated tb cases, Germany or Iran, Islamic Republic of?
- Iran, Islamic Republic of, at 65 against 64 in Germany as of 2023.
- What is the difference in treatment success rate: previously treated tb cases between Germany and Iran, Islamic Republic of?
- 1, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Germany and Iran, Islamic Republic of?
- 26 years are reported by both, from 1997 to 2023.
- How do Germany and Iran, Islamic Republic of rank globally for treatment success rate: previously treated tb cases?
- Germany ranks 109th and Iran, Islamic Republic of ranks 107th of 179 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: previously treated TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.